Table II.
Characteristics and outcomes of each patient.
| Pt. no. | Age | Gender | Major complaint | Site | Stage | Primary treatment | Surgical margin | Adjunct LAK cell therapy (no. of times) | Outcome (follow-up period, months) |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 45 | F | Cheek pain | MS | Ib | C→O→R | − | − | Death (13) |
| 2 | 67 | M | Epistaxis | N | Ia | C→O→I | − | − | Death (38) |
| 3 | 54 | M | Epistaxis | ES | Ia | C→I | − | Death (35) | |
| 4 | 74 | F | Nasal obstruction | N | Ia | O→I | + | + (32) | Death (64) |
| 5 | 54 | F | Nasal obstruction | N | Ia | O→I | − | + (6) | Death (42) |
| 6 | 68 | F | Nasal obstruction | N | Ia | C→O→I | − | + (13) | Death (115) |
| 7 | 40 | F | Epistaxis | N | Ib | C→O→I | + | + (15) | Death (35) |
| 8 | 56 | M | Epistaxis | N | Ib | O→I | + | + (23) | Death (89) |
| 9 | 74 | F | Nasal obstruction | N | Ib | O→C→I | − | − | Alive (65) |
| 10 | 40 | F | Asymptomatic | SS | III | R→C→I | + (22) | Alive (62) | |
| 11 | 72 | F | Exophthalmos | MS | Ib | C→I | − | Alive (31) | |
| 12 | 69 | F | Neck tumor | MS | II | C→O→I | − | − | Alive (31) |
| 13 | 78 | F | Epistaxis | N | Ib | C→O→I | − | + (6) | Alive (10) |
MS, maxillary sinus; ES, ethmoidal sinus; SS, sphenoidal sinus; N, nasal cavity. C, chemotherapy; O, operation; I, immunotherapy.